Alkermes Plc (ALKS)
US$ 31.783.92%
Price Chart
Key Statistics
Market Cap
$ 5.05B
P/E Ratio
14.58
Revenue (TTM)
$ 1.51B
Volume
3.42M
52W High
$ 36.45
52W Low
$ 22.90
Dividend Yield
0.00%
Beta
0.47
Technicals
50-Day MA
31.1992
200-Day MA
29.6864
52 Week High
36.45
52 Week Low
22.9
About ALKS
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Irelan.
Employees
1800
Headquarters
Dublin, Ireland
CEO
Mr. Richard F. Pops
Latest News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
28.83
Percentile: 53.12
Environmental Risk Score
0.37
Percentile: 1
Social Risk Score
17.49
Percentile: 1
Governance Risk Score
8.71
Percentile: 1
Controversy Level
ESG data provided by Sustainalytics, Inc.
ALKS
Category Average
1Low Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg